NCT04433858 An Open Label Study of the Safety and Efficacy of Psilocybin in Participants With Treatment-Resistant Depression (P-TRD) Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT04433845 The Safety and Efficacy of Psilocybin in Participants With Type 2 Bipolar Disorder (BP-II) Depression. Status UNKNOWN Phase PHASE2
NCT04243798 Establishing a Dose-response Relationship With Accelerated Transcranial Magnetic Stimulation Status COMPLETED Phase NA
NCT04226963 A Naturalistic Study of Ketamine for Treatment Resistant Mood Disorders Status COMPLETED Phase N/A
NCT04226352 Three Dosing Regimens of Dextromethorphan (DXM) Reportedly Used in Major Depressive Disorder Status COMPLETED Phase PHASE1
NCT04199143 Brain Reactivity to Nitrous Oxyde in Depression : an MRI and Ultrasound Study (PROTOBRAIN Pilote) Status COMPLETED Phase NA
NCT04195308 SAINT for Treatment of Preoperative Depression to Reduce Opioid Use Following Arthroplasty Status WITHDRAWN Phase NA
NCT04171193 Efficacy of Deep Anaesthesia With Isoflurane as a Fast-response Antidepressant Agent Status UNKNOWN Phase PHASE2
NCT04101474 Role Of Ketamine in Treatment-Resistant Major Depressive Disorder And Its Effect on Suicidality Status COMPLETED Phase NA
NCT04076124 Brain-derived Neurotrophic Factor and the Antidepressant Efficacy of Brain Stimulation Status UNKNOWN Phase NA
NCT04039022 Open-Label Safety Study of AXS-05 in Subjects With Depression Status COMPLETED Phase PHASE3
NCT04037592 Dorsomedial Prefrontal Cortex and the Antidepressant Efficacy of Theta Burst Stimulation in Depressed Patients Status COMPLETED Phase NA